rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Bal Pharma Ltd. - Research Center
524824 BALPHARMA Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Income
Operating income 280.37 249.31 170.67 223.08 209.85
Expenses
Material consumed 166.50 150.83 84.54 117.23 101.09
Manufacturing expenses - 4.70 1.14 2.74 2.61
Personnel expenses 44.46 39.62 48.77 48.45 49.61
Selling expenses - 1.41 3.19 2.62 3.63
Adminstrative expenses 46.21 26.43 26.28 31.73 30.29
Expenses capitalised - - - - -
Cost of sales 257.16 222.99 163.92 202.77 187.23
Operating profit 23.20 26.32 6.75 20.31 22.62
Other recurring income 6.49 2.69 3.62 2.75 1.67
Adjusted PBDIT 29.69 29.01 10.37 23.05 24.29
Financial expenses 10.40 11.96 12.42 12.53 9.11
Depreciation 7.24 7.26 7.03 6.12 6.73
Other write offs - - - - -
Adjusted PBT 12.06 9.80 -9.08 4.41 8.45
Tax charges 3.48 0.70 -0.17 -2.35 2.52
Adjusted PAT 8.58 9.10 -8.90 6.76 5.94
Non recurring items -0.01 - - - -
Other non cash adjustments - - - - -
Reported net profit 8.57 9.10 -8.90 6.76 5.94
Earnigs before appropriation 8.57 35.27 27.88 38.49 31.73
Equity dividend - - 1.13 1.71 -
Preference dividend - - - - -
Dividend tax - - 0.29 - -
Retained earnings 8.57 35.27 26.47 36.79 31.73

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips
Close
Add Bal Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bal Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close